[目的]探讨传统遮盖疗法联合综合训练治疗 4～8 岁屈光参差性弱视患儿的效果.[方法]选取本院2016 年 1 月至 2018年 2 月收治的 84例4～8 岁屈光参差性弱视患儿患者,随机分为对照组和观察组各 42 例.对照组患儿实施传统的遮盖疗法,观察组患儿在对照组的基础上联合综合训练.比较两组患儿的治疗效果.[结果]观察组治疗有效率显著高于对照组(P ＜0.05).两组患儿的视力情况比较,差异无统计学意义(P ＞0.05);治疗后,观察组视力优于对照组,差异有统计学意义(P ＜0.05).观察组患儿治疗满意度显著高于对照组(P ＜0.05).[结论]传统的遮盖疗法联合综合训练治疗 4～8 岁屈光参差性弱视患儿,整体治疗效果理想,可提高患儿戴镜视力,操作简单,值得临床推广应用.“,”[Objective]To investigate the clinical effect of traditional occlusion therapy combined with comprehensive training on ametropia amblyopia children aged 4～8 years old.[Methods]A total of 84 children (aged 4～8 years old)with ametropia amblyopia in our hospital from January 2016 to February 2018 were selected.According to the random number table method,the patients were divided into the control group and the observation group,with 42 cases in each group.The children in the control group received traditional occlusion therapy;the children in the observation group received traditional occlusion therapy combined comprehensive training.The therapeutic effects of the two groups were compared.[Results]Before treatment,there was no significant difference in the visual acuity between the two groups (P ＞0.05).After treatment,the visual acuity of the ametropia amblyopia children in the observation group was better than that in the control group,and the difference was statistically significant (P ＜0.05).The effective rate of treatments in children with ametropia amblyopia in the observation group was 95.24%,which was higher than that in the control group 80.95%,and the difference was statistically significant (P ＜0.05).The treatment satisfaction of 4～8 yearold ametropia amblyopia children in the observation group was 100%,which was higher than that in the control group (88.10%);the difference was statistically significant (P ＜0.05).[Conclusion]Traditional occlusion therapy combined with comprehensive training in children with ametropia amblyopia aged 4 to 8 years has an ideal overall therapeutic effect,which can improve the vi sion of children with glasses and is simple to operate and worthy of clinical application.